Rani Therapeutics Stock

ranitherapeutics.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $116.33MM

Rani Therapeutics is the developer of a platform for the oral delivery of biologic drugs.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Rani Therapeutics before its IPO, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value

Powered by Forge Data

Access valuation and stock price for companies like Rani Therapeutics before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Rani Therapeutics’ stock FAQs


Can you buy Rani Therapeutics’ stock?

You can no longer buy Rani Therapeutics’ stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

Can you sell Rani Therapeutics’ stock?

You can no longer sell stock of Rani Therapeutics on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

What is Rani Therapeutics’ stock price?

The stock price of Rani Therapeutics is $3.48 as of 1/18/24.

What is Rani Therapeutics’ stock ticker symbol?

The ticker symbol of Rani Therapeutics is RANI.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Rani Therapeutics investors also invested in these private companies


Management Team

Svai Sanford
Chief Financial Officer
Talat Imran
Founder & Chief Executive Officer
Mir Hashim Ph.D
Chief Scientific Officer & Board Member

Board Members

Andrew Farquharson
InCube Ventures
Blake Byers Ph.D
Updated on: Jul 16, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.